Pennant Group, Inc.
PNTGNasdaqCIK 1766400HealthcareFiscal year ends Dec 31
Reports and events: 97 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:20 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001766400-26-000065 |
| 2026-08-0516:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000064 |
| 2026-05-2016:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-26-000056 |
| 2026-05-0616:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001766400-26-000054 |
| 2026-05-0616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000053 |
| 2026-03-3116:05 ET | DEF 14A | Proxy statementPeriod 2026-05-14 | 0001766400-26-000027 |
| 2026-02-2608:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001766400-26-000014 |
| 2026-02-2516:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000011 |
| 2025-12-1719:02 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001766400-25-000147 |
| 2025-11-0516:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001766400-25-000141 |
| 2025-11-0516:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001766400-25-000139 |
| 2025-11-0516:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000137 |
| 2025-10-0214:52 ET | 8-K/A | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000116 |
| 2025-10-0218:39 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001766400-25-000114 |
| 2025-10-0218:39 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000113 |
| 2025-08-0616:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001766400-25-000103 |
| 2025-08-0616:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000102 |
| 2025-05-2016:08 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-25-000071 |
| 2025-05-0616:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001766400-25-000069 |
| 2025-05-0616:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000068 |
| 2025-05-0117:02 ET | 8-K | 1.01 Entry into a material agreement | 0001766400-25-000056 |
| 2025-04-1716:09 ET | DEF 14A | Proxy statementPeriod 2025-05-16 | 0001766400-25-000038 |
| 2025-02-2716:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000025 |
| 2025-02-2716:08 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001766400-25-000024 |
| 2025-01-0216:07 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0001766400-25-000003 |
| 2024-11-0616:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001766400-24-000128 |
| 2024-11-0616:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-24-000127 |
| 2024-10-0416:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001766400-24-000104 |
| 2024-08-0616:09 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001766400-24-000096 |
| 2024-08-0616:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-24-000095 |
| 2024-08-0116:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001766400-24-000090 |
| 2024-07-1112:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001766400-24-000070 |
| 2024-05-2911:39 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-24-000063 |
| 2024-05-0616:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001766400-24-000056 |
| 2024-05-0616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001766400-24-000055 |
| 2024-04-1116:06 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001766400-24-000036 |
| 2024-03-1212:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-24-000031 |
| 2024-02-2816:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001766400-24-000022 |
| 2024-02-2816:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-24-000020 |
| 2023-11-0716:12 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001766400-23-000127 |
| 2023-11-0716:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000126 |
| 2023-08-0816:08 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001766400-23-000095 |
| 2023-08-0816:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000094 |
| 2023-06-1216:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001766400-23-000073 |
| 2023-05-2516:09 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-23-000068 |
| 2023-05-2216:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000066 |
| 2023-05-0416:09 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001766400-23-000061 |
| 2023-05-0416:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000060 |
| 2023-04-1316:07 ET | DEF 14A | Proxy statement | 0001766400-23-000041 |
| 2023-02-2816:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000028 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:38 ET. Listed shows no prices and gives no investment advice.